BIO-PATH HOLDINGS, INC. (BPTH) 2025年第一季度财报(10-Q)「NASDAQ」.pdf

1、Table of ContentsUNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington,D.C.20549FORM 10-Q(Mark One)QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIESEXCHANGE ACT OF 1934For the quarterly period ended March 31,2025OrTRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES

2、EXCHANGE ACT OF 1934For the transition period from _ to _Commission file number:001-36333Bio-Path Holdings,Inc.(Exact name of registrant as specified in its charter)Delaware 87-0652870(State or other jurisdiction of(I.R.S.Employerincorporation or organization)Identification No.)4710 Bellaire Bouleva

3、rd,Suite 210,Bellaire,Texas 77401(Address of principal executive offices)(Zip Code)(832)742-1357(Registrants telephone number,including area code)Securities registered pursuant to Section 12(b)of the Act:None.Indicate by check mark whether the registrant(1)has filed all reports required to be filed

4、by Section 13 or 15(d)ofthe Securities Exchange Act of 1934 during the preceding 12 months(or for such shorter period that the registrantwas required to file such reports),and(2)has been subject to such filing requirements for the past 90 days.Yes No Indicate by check mark whether the registrant has

5、 submitted electronically every Interactive Data File required to besubmitted pursuant to Rule 405 of Regulation S-T(232.405 of this chapter)during the preceding 12 months(or forsuch shorter period that the registrant was required to submit such files).Yes No Indicate by check mark whether the regis

6、trant is a large accelerated filer,an accelerated filer,a non-accelerated filer,a smaller reporting company,or an emerging growth company.See the definitions of“large accelerated filer,”“accelerated filer,”“smaller reporting company,”and“emerging growth company”in Rule 12b-2 of the ExchangeAct.Large